EYE.AX
Latest Trade
0.33AUDChange
--(--)Today's Range
-
--52 Week Range
-
0.79As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay
Previous Close | 0.33 |
|---|---|
Open | -- |
Volume | -- |
3M AVG Volume | 2.12 |
Today's High | -- |
Today's Low | -- |
52 Week High | 0.79 |
52 Week Low | 0.28 |
Shares Out (MIL) | 143.69 |
Market Cap (MIL) | 48.85 |
Forward P/E | -- |
Dividend (Yield %) | -- |
Nova Eye Medical Posts FY Net Profit After Tax A$35.6 Mln
Nova Eye Medical Updates On Australian Taxation Office Ruling On Capital Return
Lumibird Receives ACCC Go-Ahead To Buy Ellex's Laser And Ultrasound Business
Nova Eye Medical Limited, formerly Ellex Medical Lasers Limited, is an Australia-based medical technology company. The Company develops, manufactures and sells a portfolio of ophthalmic treatment technologies and devices. Its technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye’s natural outflow pathway to lower pressure inside the eye. The Molteno3 glaucoma drainage device platform is designed to manage surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control. It also provides retinal rejuvenation therapy (2RT) laser technology as a therapy for patients with intermediate age-related macular degeneration.
Industry
Medical Equipment & Supplies
Executive Leadership
Victor Previn
Executive Chairman of the Board
Mike Southard
Executive Director
Simon Gray
Joint Company Secretary
Tom Spurling
Director
Alexander M. Sundich
Non-Executive Director
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 4.02 |
Price To Book (MRQ) | 1.32 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 8.92 |
LT Debt To Equity (MRQ) | 3.99 |
Return on Investment (TTM) | -16.89 |
Return on Equity (TTM) | -12.02 |
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.